Vorinostat Completed Phase 1 Trials for Recurrent Adult Acute Lymphoblastic Leukemia / Recurrent Adult Diffuse Small Cleaved Cell Lymphoma / Recurrent Mycosis Fungoides and Sezary Syndrome / Adult T Acute Lymphoblastic Leukemia / Nodal Marginal Zone Lymphoma / Anaplastic Large Cell Lymphoma / Angioimmunoblastic T-Cell Lymphoma / Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma / Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma / Refractory Chronic Lymphocytic Leukemia / Splenic Marginal Zone Lymphoma / Recurrent Grade 3 Follicular Lymphoma / Intraocular Lymphoma / Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma / Recurrent Mantle Cell Lymphoma / Recurrent Adult Grade III Lymphomatoid Granulomatosis / Recurrent Adult T-Cell Leukemia/Lymphoma / Recurrent Small Lymphocytic Lymphoma / Cutaneous B-Cell Non-Hodgkin Lymphoma / Chronic Lymphocytic Leukaemia (CLL) / Lymphomatous Involvement of Non-Cutaneous Extranodal Site / T-Cell Large Granular Lymphocyte Leukemia / Recurrent Marginal Zone Lymphoma / Recurrent Adult Hodgkin's Lymphoma / Recurrent Non-Hodgkin Lymphoma / Recurrent Adult Lymphoblastic Lymphoma / Waldenström's Macroglobulinemia (WM) / Recurrent Adult Burkitt Lymphoma / Hepatosplenic T-Cell Lymphoma / Recurrent Adult Diffuse Large Cell Lymphoma / Adult B Acute Lymphoblastic Leukemia / Recurrent Grade 1 Follicular Lymphoma / Primary Cutaneous B-Cell Non-Hodgkin Lymphoma / Recurrent Adult Diffuse Mixed Cell Lymphoma / Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue / Recurrent Adult Immunoblastic Lymphoma / Small Intestinal Lymphoma / Recurrent Grade 2 Follicular Lymphoma / Testicular Lymphoma / Refractory Hairy Cell Leukemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01567709Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma